🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The AngioDynamics, Inc. Life Scientific Symposium is truly border-breaking for partnership and innovation. 🙏🏼Thanks to let me introduce SmartPAN☄️ pancreatic leakage indicator to the next level🚀!

What could be done to reduce the complications of pancreatic surgery? Could #AI be used in pancreatic surgery? To know the answer, listen to DR. Thomas Pausch, MD From the Department of General, Visceral and Transplantation Surgery at Heidelberg University Hospital in Germany.

Redeye leaves an initial comment following the Q2 report published by Magle this morning. The second quarter of 2024 for Magle was primarily marked by the merger and acquisitions of Amniotics and pK Chemicals. $MAGLE redeye.se/research/10232…

linkedin.com/posts/maglepha…

linkedin.com/posts/maglepha…

linkedin.com/feed/update/ur…

linkedin.com/posts/maglepha…

At Magle PharmaCept, we know that practitioners strive for excellence on multiple fronts. The individual patient’s care is the key focus, and improving health with minimized complications. #Innovation #MaglePharmaCept #MagleGroup linkedin.com/feed/update/ur…

linkedin.com/posts/maglepha…

What a great experience at CIRSE 2024! Check out the post below for the insights! linkedin.com/posts/maglepha… hashtag#CIRSE2024 hashtag#MagleGroup hashtag#MaglePharmaCept

Patient Centricity! As our aspiration is “Bringing Life Changing Innovations to Patients”, we prioritize patients in developing innovative solutions to improve their quality of life. #DSM #HealthcareInnovation #MagleGroup #EmboCeptSDSM50mm #SmartPAN linkedin.com/posts/maglepha…

To learn more about how the use of #SmartPAN could make pancreatic surgery safer, click 👇 to watch the video. Stay tuned! #DiscoverLeaks #Detect_pancreatic_leakage #HeidelbergUniversityHospital linkedin.com/posts/maglepha…

💜 November in Purple! 💜 This November, we’re wearing purple and changing our logo to support pancreatic cancer patients and raise awareness. Stay tuned! #pancreaticcancerawarenessmonth linkedin.com/posts/maglepha…

Magle Group Announces Publication of Prospective HepaStar Trial Results Highlighting Promising Outcomes for DSM-TACE in Hepatocellular Carcinoma. Click 👇 now and follow us! #MagleGroup #MaglePharmaCept #DSM #Embolization #EmboCept®SDSM50µm linkedin.com/posts/maglepha…

"DSM-TACE results in promising survival rates and low rates of treatment-related adverse events," says PD Dr. Med. Federico Collettini, senior attending physician at the renowned Charité – Universitätsmedizin Berlin, Germany. linkedin.com/posts/maglepha…

linkedin.com/posts/maglepha…

linkedin.com/posts/maglepha…

Exciting Times at hashtag#DPC2025! What an incredible time! DPC 2025 brought together top experts, cutting-edge research, and valuable insights into modern pancreatic surgery and pancreatic cancer therapy. linkedin.com/posts/maglepha…